180 related articles for article (PubMed ID: 10397328)
1. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase.
Bell PB; Rooney N; Bosanquet AG
Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328
[TBL] [Abstract][Full Text] [Related]
2. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
4. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.
Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A
Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
Dunphy CH; Wheaton SE; Perkins SL
Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
[TBL] [Abstract][Full Text] [Related]
7. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
8. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
9. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse.
Bosanquet AG; Bell PB; Rooney N
Anticancer Res; 1999; 19(6B):5329-34. PubMed ID: 10697557
[TBL] [Abstract][Full Text] [Related]
11. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
Dorfman DM; Pinkus GS
Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704
[TBL] [Abstract][Full Text] [Related]
12. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
14. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
16. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
17. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
18. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
[TBL] [Abstract][Full Text] [Related]
19. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
